Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:34 AM
Ignite Modification Date:
2025-12-25 @ 1:34 AM
NCT ID:
NCT02948894
Eligibility Criteria:
Inclusion Criteria:
* Asians (Chinese, Malay or Indians) living in Singapore
* Symptomatic HF (NYHA classes II-III) due to ischemic cardiomyopathy
* LVEF \<45% (as determined by echocardiography)
* Clinical stability for ≥1 month
* Optimal medical therapy including a diuretic, an angiotensin-converting enzyme inhibitor or an angiotensin receptor blocker, and a beta-blocker. The doses of these background medications should be stable for ≥1 month.
Exclusion Criteria:
* Known OSA on treatment
* Acute coronary syndrome within the preceding 3 months
* Severe valvular heart disease
* Sustained ventricular arrhythmia
* Stroke with residual neurological deficits
* Contraindication to CMRsuch as a pacemaker or cardioverter-defibrillator implant.
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT02948894
Study Brief:
Protocol Section:
NCT02948894